Donghua Zhang
Clinical trials sponsored by Donghua Zhang, explained in plain language.
-
New CAR-T therapy targets tough blood cancers
Disease control Recruiting nowThis study tests a new treatment called BAFFR CAR-T for people with B-cell blood cancers that have not responded to standard therapy or have returned. The therapy uses a patient's own immune cells, modified to attack cancer cells. The goal is to see if it is safe and helps patien…
Phase: NA • Sponsor: Donghua Zhang • Aim: Disease control
Last updated May 17, 2026 03:25 UTC
-
Immune cell boost may keep leukemia at bay after transplant
Disease control Recruiting nowThis study tests whether giving special immune cells (γδ T cells) after a stem cell transplant can help prevent high-risk acute myeloid leukemia from returning. About 40 adults aged 18 to 65 will receive these cells and be monitored for relapse-free survival. The goal is to see i…
Phase: NA • Sponsor: Donghua Zhang • Aim: Disease control
Last updated May 15, 2026 11:57 UTC